Page 8 of 14
This is a working document prepared by NIOSH’s Division of Compensation Analysis and Support (DCAS) or its contractor for
use in discussions with the ABRWH or its Working Groups or Subcommittees. Draft, preliminary, interim, and White Paper
documents are not final NIOSH or ABRWH (or their technical support and review contractors) positions unless specifically
marked as such. This document represents preliminary positions taken on technical issues prepared by NIOSH or its contractor.
NOTICE: This report has been reviewed to identify and redact any information that is protected by the Privacy Act, 5 USC §
552a and has been cleared for distribution.
DAC, and all required respiratory protection. Notably, six RWPs associated with work in
the beam line/flight path area required nasal swipes; all results were reported as having
no detectable activity.
Aside from the nasal swipe requirements, no additional bioassay was initially indicated
as required on any TA-53 RWPs. As determined appropriate, however, follow-up
bioassay (e.g., in vivo, in vitro, or chest count) was performed.
At least one nasal swipe result was recorded in 91 of the 192 RWPs requiring nasal
swipes; in total, 802 nasal swipe results were recorded within these 91 RWPs. Within
the 802 nasal swipe results, two positive alpha results measured at 12 and 133
disintegrations per minute (dpm), and 30 positive beta results ranged from 48 dpm to
662 dpm.
LANL required initiation of Radiation Protection Observation Reports (formerly known as
Radiation Incident Reports) if the sum of readings in both nostrils for nasal swipes was
greater than or equal to 50 dpm for alpha, and/or greater than or equal to 500 dpm for
beta. A total of three individuals had nasal swipe results that exceeded these
thresholds. Nasal swipes for one of the individuals indicated beta results above 500
dpm. Follow-up in vivo monitoring was performed for this person, and the results
showed no detectable activity. The Radiation Protection Observation Report initiated for
this individual also noted that LANL Health Physics staff suspected the elevated nasal
smears were a result of cross-contamination. A second Radiation Protection
Observation Report was initiated for an employee whose nasal swipes exceeded both
the alpha and beta action limits. No information regarding follow-up bioassay was
observed in this report. However, NIOSH determined this individual was on routine in
vivo bioassay, and none of this person’s results were greater than the minimum
detectable activity. The third Radiation Protection Observation Report was initiated for
an employee (unidentified) whose nasal swipes exceeded the beta limit.
Seven individuals identified as having positive nasal smears below limits either received
special request chest counts and/or were on a routine in vivo program. One of the
seven results had no associated name. One of the other individuals did not appear to be
on a routine bioassay program but did have a baseline whole body count and in vitro
results approximately six months before the nasal swipes were taken.
Though NIOSH cannot confirm, the absence of nasal swipe results in 101 of the RWPs
may result from on-the-job adjustments to monitoring requirements. As often noted in
RWPs, attendant RCTs had the authority to adjust monitoring (and PPE) as they felt
necessary, and 80 of the 101 RWPs included such stipulations. Of the remaining
RWPs, 16 contained no indication that nasal swipes were needed in the “post-job
review” section. However, of those 16 RWPs, 3 RWPs stated “no information available,”
so those appear incomplete. An additional 4 RWPs had associated “post-job review”
sections indicating that nasal swipes were taken, but records of the results are not